← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2001Last known activity
Sep 1, 2025
Timeline
1990s
- Jan 1, 1999
Intergroupe Francophone de Cancerologie Thoracique— Founded
Drugs by trial phase (33 distinct, 39 trials)
Phase 3 (18 own, 0 via acquisition)
Indications
Recent trials (39)
- NCT06937905Lead sponsorPhase 3Sep 1, 2025
- NCT06840834Lead sponsorPhase 2Apr 1, 2025
- NCT06656598Lead sponsorPhase 2Jan 31, 2025
- NCT05856695Lead sponsorPhase 2Nov 17, 2023
- NCT05781308Lead sponsorPhase 2Apr 26, 2023
- NCT05200481Lead sponsorPhase 2May 18, 2022
- NCT05255302Lead sponsorPhase 2/Phase 3May 2, 2022
- NCT04621188Lead sponsorPhase 2Jan 31, 2021
- NCT04526782Lead sponsorPhase 2Jan 19, 2021
- NCT04233021Lead sponsorPhase 2Jan 31, 2020
- NCT04108026Lead sponsorPhase 2Oct 31, 2019
- NCT04111705Lead sponsorPhase 2Oct 31, 2019
- NCT03977194Lead sponsorPhase 3Jun 30, 2019
- NCT03845270Lead sponsorPhase 2May 31, 2019
- NCT03591731Lead sponsorPhase 2Sep 30, 2018
Details
- Founded
- Paris, FR Jan 1, 1999
- Last known activity
- Sep 1, 2025